BIOTRON LIMITED - Announcements

20.0%

0.2¢

Market Cap $2.654M

Healthcare Biotechnology

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the... Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1 and COVID-19, and additional preclinical programs including Hepatitis B Virus (HBV). In addition, the Company has several early-stage programs designing drugs that target a class of virus protein known as viroporins, which have a key role in the virus life cycle of a range of viruses, such as Coronavirus, Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Its proprietary primary bacterial cell-based screening platform enables rapid screening of target viroporin proteins. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. The Company also has a portfolio of preclinical antiviral programs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	365.37KB	Share
BIT	Director Appointment Michael Medway		16/07/25	281.52KB	Share
BIT	Hepatitis B Virus Program Update	PRICE SENSITIVE	24/06/25	138.28KB	Share
BIT	Details of Share Registry address		16/06/25	158.66KB	Share
BIT	Biotron Investor Webinar		23/05/25	435.71KB	Share
BIT	Company Secretary Appointment/Resignation		02/05/25	40.34KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/25	349.8KB	Share
BIT	Change of Director's Interest Notice		10/04/25	269.79KB	Share
BIT	Application for quotation of securities - BIT		08/04/25	15.47KB	Share
BIT	Rights Issue Closed	PRICE SENSITIVE	08/04/25	133.63KB	Share
BIT	Dispatch of Rights Issue Offer documents		18/03/25	257.54KB	Share
BIT	Update on Rights Issue Timetable		13/03/25	160.74KB	Share
BIT	Update - Proposed issue of securities - BIT		13/03/25	20.15KB	Share
BIT	Replacement Prospectus	PRICE SENSITIVE	12/03/25	385.48KB	Share
BIT	Response to ASX Query Letter	PRICE SENSITIVE	12/03/25	374.05KB	Share
BIT	Update - Proposed issue of securities - BIT		10/03/25	20.15KB	Share
BIT	Delay in Offer Opening - BITR		10/03/25	152.91KB	Share
BIT	Update - Proposed issue of securities - BIT		05/03/25	19.66KB	Share
BIT	Supplementary Prospectus	PRICE SENSITIVE	05/03/25	68.87KB	Share
BIT	Commencement of Rights Trading		05/03/25	133.05KB	Share
BIT	Response to ASX Aware Query	PRICE SENSITIVE	04/03/25	1.06MB	Share
BIT	Prospectus	PRICE SENSITIVE	03/03/25	480.48KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/25	766.57KB	Share
BIT	Change of Principal Place of Business Address		28/02/25	78.52KB	Share
BIT	Cancel - Proposed issue of securities - BIT		28/02/25	17.57KB	Share
BIT	Proposed issue of securities - BIT		28/02/25	19.95KB	Share
BIT	Renounceable Rights Issue	PRICE SENSITIVE	28/02/25	162.83KB	Share
BIT	Biotron Investor Webinar		26/02/25	182.34KB	Share
BIT	Proposed issue of securities - BIT		21/02/25	17.75KB	Share
BIT	Letter to Shareholders		21/02/25	211.63KB	Share
BIT	Share Purchase Plan		21/02/25	276.73KB	Share
BIT	Updated Appendix 4C	PRICE SENSITIVE	03/02/25	169.95KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/01/25	393.34KB	Share
BIT	Change of Director's Interest Notice M.M, M.H, R.T.		28/11/24	230.25KB	Share
BIT	Final Director's Interest Notice S.P. $ S.L.		28/11/24	230.06KB	Share
BIT	Results of Meeting AGM		28/11/24	141.33KB	Share
BIT	Presentation to Annual General Meeting		28/11/24	2.2MB	Share
BIT	Agreement with C14 Consulting Group	PRICE SENSITIVE	27/11/24	168.55KB	Share
BIT	Application for quotation of securities - BIT		25/11/24	318.81KB	Share
BIT	Application for quotation of securities - BIT		19/11/24	15.36KB	Share
BIT	Revised Continuous Disclosure Policy		15/11/24	503.66KB	Share
BIT	Application for quotation of securities - BIT		12/11/24	15.36KB	Share
BIT	Cancel - Application for quotation of securities - BIT		12/11/24	14.96KB	Share
BIT	Application for quotation of securities - BIT		12/11/24	15.36KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/24	1.07MB	Share
BIT	Typographical error		25/10/24	125.47KB	Share
BIT	Option Expiry Notice		24/10/24	901.37KB	Share
BIT	Annual Report/Notice of AGM/Proxy Form		22/10/24	2.42MB	Share
BIT	$1.8M R&D Rebate Received	PRICE SENSITIVE	14/10/24	399.28KB	Share
BIT	Response to ASX Aware Query	PRICE SENSITIVE	25/09/24	1.5MB	Share
BIT	BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL	PRICE SENSITIVE	06/09/24	540.68KB	Share
BIT	Appendix 4G		30/08/24	264.8KB	Share
BIT	Corporate Governance Statement		30/08/24	216.37KB	Share
BIT	Full Year Statutory Accounts and Appendix 4E	PRICE SENSITIVE	30/08/24	1.41MB	Share
BIT	Application for quotation of securities - BIT		15/08/24	15.36KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	1.01MB	Share
BIT	Application for quotation of securities - BIT		22/07/24	15.35KB	Share
BIT	Letter to Shareholders		11/07/24	1006.55KB	Share
BIT	Webinar Investors Presentation		26/06/24	3.99MB	Share
BIT	BIOTRON CLINICAL TRIAL RESULTS WEBINAR		25/06/24	828.97KB	Share
BIT	BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives	PRICE SENSITIVE	19/06/24	711.16KB	Share
BIT	Change of Share Registry address		23/05/24	95.43KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/04/24	1MB	Share
BIT	POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV	PRICE SENSITIVE	05/04/24	670.99KB	Share
BIT	Response to ASX Price Query	PRICE SENSITIVE	27/03/24	453.67KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/24	603.88KB	Share
BIT	$1.64M R&D rebate received		08/02/24	269.89KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/24	277.88KB	Share
BIT	Shareholder Update		14/12/23	127.05KB	Share
BIT	Application for quotation of securities - BIT		01/12/23	24.61KB	Share
BIT	Change of Director's Interest Notice MM		27/11/23	197.97KB	Share
BIT	Notification of cessation of securities - BIT		27/11/23	21.45KB	Share
BIT	Results of AGM		22/11/23	92.59KB	Share
BIT	Presentation to Annual General Meeting		22/11/23	1.58MB	Share
BIT	Application for quotation of securities - BIT		10/11/23	24.66KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/10/23	1.03MB	Share
BIT	Application for quotation of securities - BIT		26/10/23	24.66KB	Share
BIT	Presentation to Investors		24/10/23	979.37KB	Share
BIT	Annual Report/Notice of Annual General Meeting/Proxy Form		20/10/23	1.33MB	Share
BIT	Application for quotation of securities - BIT		10/10/23	24.66KB	Share
BIT	Response to ASX Price Query	PRICE SENSITIVE	29/09/23	712.55KB	Share
BIT	Letter to Shareholders		26/09/23	373.27KB	Share
BIT	Response to ASX Price Query	PRICE SENSITIVE	11/09/23	665.15KB	Share
BIT	Appendix 4G		25/08/23	256.42KB	Share
BIT	Corporate Governance Statement		25/08/23	213.39KB	Share
BIT	Full Year Statutory Accounts and Appendix 4E	PRICE SENSITIVE	25/08/23	1.05MB	Share
BIT	COMPLETION OF PHASE 2 COVID CLINICAL TRIAL	PRICE SENSITIVE	16/08/23	312.28KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	475.77KB	Share
BIT	Second Site Approved for Phase 2 Covid-19 Trial	PRICE SENSITIVE	12/05/23	89.11KB	Share
BIT	Commencement Phase 2 Covid-19 Clinical Trial	PRICE SENSITIVE	04/05/23	144.72KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	1.01MB	Share
BIT	Cleansing Notice		22/03/23	99.09KB	Share
BIT	Application for quotation of securities - BIT		22/03/23	24.65KB	Share
BIT	Completion of Phase 2 HIV-1 Clinical Trials	PRICE SENSITIVE	09/03/23	403.58KB	Share
BIT	International Presentation of BIT225 COVID-19 Data	PRICE SENSITIVE	21/02/23	824.33KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	17/02/23	794.46KB	Share
BIT	Notification of cessation of securities - BIT		01/02/23	21.47KB	Share
BIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	436.71KB	Share
BIT	CLEANSING NOTICE		25/01/23	262.54KB	Share
BIT	Application for quotation of securities - BIT		25/01/23	24.68KB	Share

BIT Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	365.37KB	Share
BIT Director Appointment Michael Medway
16/07/25		281.52KB	Share
BIT Hepatitis B Virus Program Update
24/06/25	PRICE SENSITIVE	138.28KB	Share
BIT Details of Share Registry address
16/06/25		158.66KB	Share
BIT Biotron Investor Webinar
23/05/25		435.71KB	Share
BIT Company Secretary Appointment/Resignation
02/05/25		40.34KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
24/04/25	PRICE SENSITIVE	349.8KB	Share
BIT Change of Director's Interest Notice
10/04/25		269.79KB	Share
BIT Application for quotation of securities - BIT
08/04/25		15.47KB	Share
BIT Rights Issue Closed
08/04/25	PRICE SENSITIVE	133.63KB	Share
BIT Dispatch of Rights Issue Offer documents
18/03/25		257.54KB	Share
BIT Update on Rights Issue Timetable
13/03/25		160.74KB	Share
BIT Update - Proposed issue of securities - BIT
13/03/25		20.15KB	Share
BIT Replacement Prospectus
12/03/25	PRICE SENSITIVE	385.48KB	Share
BIT Response to ASX Query Letter
12/03/25	PRICE SENSITIVE	374.05KB	Share
BIT Update - Proposed issue of securities - BIT
10/03/25		20.15KB	Share
BIT Delay in Offer Opening - BITR
10/03/25		152.91KB	Share
BIT Update - Proposed issue of securities - BIT
05/03/25		19.66KB	Share
BIT Supplementary Prospectus
05/03/25	PRICE SENSITIVE	68.87KB	Share
BIT Commencement of Rights Trading
05/03/25		133.05KB	Share
BIT Response to ASX Aware Query
04/03/25	PRICE SENSITIVE	1.06MB	Share
BIT Prospectus
03/03/25	PRICE SENSITIVE	480.48KB	Share
BIT Half Yearly Report and Accounts
28/02/25	PRICE SENSITIVE	766.57KB	Share
BIT Change of Principal Place of Business Address
28/02/25		78.52KB	Share
BIT Cancel - Proposed issue of securities - BIT
28/02/25		17.57KB	Share
BIT Proposed issue of securities - BIT
28/02/25		19.95KB	Share
BIT Renounceable Rights Issue
28/02/25	PRICE SENSITIVE	162.83KB	Share
BIT Biotron Investor Webinar
26/02/25		182.34KB	Share
BIT Proposed issue of securities - BIT
21/02/25		17.75KB	Share
BIT Letter to Shareholders
21/02/25		211.63KB	Share
BIT Share Purchase Plan
21/02/25		276.73KB	Share
BIT Updated Appendix 4C
03/02/25	PRICE SENSITIVE	169.95KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
24/01/25	PRICE SENSITIVE	393.34KB	Share
BIT Change of Director's Interest Notice M.M, M.H, R.T.
28/11/24		230.25KB	Share
BIT Final Director's Interest Notice S.P. $ S.L.
28/11/24		230.06KB	Share
BIT Results of Meeting AGM
28/11/24		141.33KB	Share
BIT Presentation to Annual General Meeting
28/11/24		2.2MB	Share
BIT Agreement with C14 Consulting Group
27/11/24	PRICE SENSITIVE	168.55KB	Share
BIT Application for quotation of securities - BIT
25/11/24		318.81KB	Share
BIT Application for quotation of securities - BIT
19/11/24		15.36KB	Share
BIT Revised Continuous Disclosure Policy
15/11/24		503.66KB	Share
BIT Application for quotation of securities - BIT
12/11/24		15.36KB	Share
BIT Cancel - Application for quotation of securities - BIT
12/11/24		14.96KB	Share
BIT Application for quotation of securities - BIT
12/11/24		15.36KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
30/10/24	PRICE SENSITIVE	1.07MB	Share
BIT Typographical error
25/10/24		125.47KB	Share
BIT Option Expiry Notice
24/10/24		901.37KB	Share
BIT Annual Report/Notice of AGM/Proxy Form
22/10/24		2.42MB	Share
BIT $1.8M R&D Rebate Received
14/10/24	PRICE SENSITIVE	399.28KB	Share
BIT Response to ASX Aware Query
25/09/24	PRICE SENSITIVE	1.5MB	Share
BIT BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
06/09/24	PRICE SENSITIVE	540.68KB	Share
BIT Appendix 4G
30/08/24		264.8KB	Share
BIT Corporate Governance Statement
30/08/24		216.37KB	Share
BIT Full Year Statutory Accounts and Appendix 4E
30/08/24	PRICE SENSITIVE	1.41MB	Share
BIT Application for quotation of securities - BIT
15/08/24		15.36KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	1.01MB	Share
BIT Application for quotation of securities - BIT
22/07/24		15.35KB	Share
BIT Letter to Shareholders
11/07/24		1006.55KB	Share
BIT Webinar Investors Presentation
26/06/24		3.99MB	Share
BIT BIOTRON CLINICAL TRIAL RESULTS WEBINAR
25/06/24		828.97KB	Share
BIT BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
19/06/24	PRICE SENSITIVE	711.16KB	Share
BIT Change of Share Registry address
23/05/24		95.43KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
26/04/24	PRICE SENSITIVE	1MB	Share
BIT POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
05/04/24	PRICE SENSITIVE	670.99KB	Share
BIT Response to ASX Price Query
27/03/24	PRICE SENSITIVE	453.67KB	Share
BIT Half Yearly Report and Accounts
27/02/24	PRICE SENSITIVE	603.88KB	Share
BIT $1.64M R&D rebate received
08/02/24		269.89KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24	PRICE SENSITIVE	277.88KB	Share
BIT Shareholder Update
14/12/23		127.05KB	Share
BIT Application for quotation of securities - BIT
01/12/23		24.61KB	Share
BIT Change of Director's Interest Notice MM
27/11/23		197.97KB	Share
BIT Notification of cessation of securities - BIT
27/11/23		21.45KB	Share
BIT Results of AGM
22/11/23		92.59KB	Share
BIT Presentation to Annual General Meeting
22/11/23		1.58MB	Share
BIT Application for quotation of securities - BIT
10/11/23		24.66KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
27/10/23	PRICE SENSITIVE	1.03MB	Share
BIT Application for quotation of securities - BIT
26/10/23		24.66KB	Share
BIT Presentation to Investors
24/10/23		979.37KB	Share
BIT Annual Report/Notice of Annual General Meeting/Proxy Form
20/10/23		1.33MB	Share
BIT Application for quotation of securities - BIT
10/10/23		24.66KB	Share
BIT Response to ASX Price Query
29/09/23	PRICE SENSITIVE	712.55KB	Share
BIT Letter to Shareholders
26/09/23		373.27KB	Share
BIT Response to ASX Price Query
11/09/23	PRICE SENSITIVE	665.15KB	Share
BIT Appendix 4G
25/08/23		256.42KB	Share
BIT Corporate Governance Statement
25/08/23		213.39KB	Share
BIT Full Year Statutory Accounts and Appendix 4E
25/08/23	PRICE SENSITIVE	1.05MB	Share
BIT COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
16/08/23	PRICE SENSITIVE	312.28KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	475.77KB	Share
BIT Second Site Approved for Phase 2 Covid-19 Trial
12/05/23	PRICE SENSITIVE	89.11KB	Share
BIT Commencement Phase 2 Covid-19 Clinical Trial
04/05/23	PRICE SENSITIVE	144.72KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	1.01MB	Share
BIT Cleansing Notice
22/03/23		99.09KB	Share
BIT Application for quotation of securities - BIT
22/03/23		24.65KB	Share
BIT Completion of Phase 2 HIV-1 Clinical Trials
09/03/23	PRICE SENSITIVE	403.58KB	Share
BIT International Presentation of BIT225 COVID-19 Data
21/02/23	PRICE SENSITIVE	824.33KB	Share
BIT Half Yearly Report and Accounts
17/02/23	PRICE SENSITIVE	794.46KB	Share
BIT Notification of cessation of securities - BIT
01/02/23		21.47KB	Share
BIT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	436.71KB	Share
BIT CLEANSING NOTICE
25/01/23		262.54KB	Share
BIT Application for quotation of securities - BIT
25/01/23		24.68KB	Share

REFRESH

1 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change -0.001(20.0%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.2¢	$2.28K	913.3K

Buyers (Bids)

No.	Vol.	Price($)
44	34518629	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	15608554	19

View Market Depth

No.	Vol.	Price($)
44	34518629	0.002
34	94302000	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	15608554	19
0.004	16987080	16
0.005	6690600	5
0.006	1200000	2
0.007	572733	2

Last trade - 16.10pm 30/07/2025 (20 minute delay)

BIT (ASX) Chart

BIOTRON LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available